Aggregated
50% success rate- Bullish
- 4
- Hold
- 0
- Bearish
- 0
Bernstein
At Bernstein, this analyst has issued 4 tracked ratings across 4 distinct tickers, focusing exclusively on one source with a 50% success rate on the captured sample as of October 17, 2024.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| ABBV | 2024-10-17 | buy | $203.00 | Aggregated |
| ABBVABBVIE INC | 2024-10-17 | unknown | $203.00 | Aggregated |
| AMGN | 2024-10-17 | buy | $380.00 | Aggregated |
| AMGNAMGEN INC. | 2024-10-17 | unknown | $380.00 | Aggregated |
| GILD | 2024-10-17 | buy | $105.00 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 2024-10-17 | unknown | $105.00 | Aggregated |
| REGN | 2024-03-11 | buy | $1125.00 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 2024-03-11 | unknown | $1125.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| ABBV | 2 | 2024-10-17 | Aggregated |
| ABBVABBVIE INC | 1 | 2024-10-17 | Aggregated |
| AMGN | 2 | 2024-10-17 | Aggregated |
| AMGNAMGEN INC. | 1 | 2024-10-17 | Aggregated |
| GILD | 2 | 2024-10-17 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 1 | 2024-10-17 | Aggregated |
| REGN | 2 | 2024-03-11 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 1 | 2024-03-11 | Aggregated |